Stonepine Capital Management LLC purchased a new position in shares of Apollo Endosurgery, Inc. (NASDAQ:APEN) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 2,364,707 shares of the biotechnology company’s stock, valued at approximately $11,067,000. Apollo Endosurgery accounts for approximately 6.5% of Stonepine Capital Management LLC’s portfolio, making the stock its 7th biggest holding. Stonepine Capital Management LLC owned approximately 13.68% of Apollo Endosurgery at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the company. JPMorgan Chase & Co. bought a new position in shares of Apollo Endosurgery during the 3rd quarter worth $119,000. Woodmont Investment Counsel LLC bought a new position in shares of Apollo Endosurgery during the 3rd quarter worth $220,000. Finally, Russell Investments Group Ltd. bought a new position in shares of Apollo Endosurgery during the 3rd quarter worth $1,288,000. Institutional investors own 23.67% of the company’s stock.
APEN has been the subject of several research reports. Northland Securities initiated coverage on Apollo Endosurgery in a research note on Tuesday, September 26th. They set an “outperform” rating and a $12.00 price target for the company. Zacks Investment Research upgraded Apollo Endosurgery from a “hold” rating to a “buy” rating and set a $4.75 price target for the company in a research note on Thursday, November 2nd. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $9.44.
In other news, VP Bret Schwartzhoff purchased 9,500 shares of the business’s stock in a transaction dated Tuesday, November 7th. The stock was bought at an average price of $4.24 per share, for a total transaction of $40,280.00. Following the purchase, the vice president now owns 15,631 shares of the company’s stock, valued at $66,275.44. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 74.20% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: “Stonepine Capital Management LLC Invests $11.07 Million in Apollo Endosurgery, Inc. (APEN) Stock” was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://sportsperspectives.com/2017/12/04/stonepine-capital-management-llc-invests-11-07-million-in-apollo-endosurgery-inc-apen-stock.html.
Apollo Endosurgery Profile
Apollo Endosurgery, Inc, formerly Lpath, Inc, is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company’s device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80 countries.
Want to see what other hedge funds are holding APEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Apollo Endosurgery, Inc. (NASDAQ:APEN).
Receive News & Ratings for Apollo Endosurgery Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Endosurgery Inc. and related companies with MarketBeat.com's FREE daily email newsletter.